Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma.[1][2]
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | B-lymphoma cell |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
References
edit- ^ "International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (4). 1993. Archived from the original (PDF) on 14 June 2007.
- ^ Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, Chugh VK (2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.85-99&rft.date=2018&rft_id=https://api.semanticscholar.org/CorpusID:27211386#id-name=S2CID&rft_id=info:pmid/28799485&rft_id=info:doi/10.2174/1574884712666170809124728&rft.aulast=Singh&rft.aufirst=S&rft.au=Kumar, NK&rft.au=Dwiwedi, P&rft.au=Charan, J&rft.au=Kaur, R&rft.au=Sidhu, P&rft.au=Chugh, VK&rfr_id=info:sid/en.wikipedia.org:Detumomab" class="Z3988">
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |